Showing results 1 to 4 of 4
Issue Date | Title | Author(s) | Type |
---|---|---|---|
2024 | Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity | 문영철; 박영훈; 이세원 | Article |
2022 | Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia | 성주명; 문영철; 김대영; 박영훈 | Article |
2022 | Management of immune thrombocytopenia: 2022 update of Korean experts recommendations | 문영철; 박영훈 | Review |
2023 | Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high-risk essential thrombocythemia | 문영철; 박동진; 박영훈; 이세원 | Article |